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1. Introduction
People who work in the field of molecular imprinting often 
describe these materials as “plastibodies”, a sort of artificial 
antibodies which share with natural antibodies the same binding 
behaviour [1]. In fact, molecularly imprinted polymers (MIPs) 
show a set of binding properties apparently very similar to those 
of natural antibodies (immunoglobulins): a marked selectivity 
towards the related ligands (antigens for antibodies, template 
molecules for MIPs) and binding properties raising form multiple 
reversible non-covalent interactions, characterized by well-
defined thermodynamics and kinetics. These similarities (Table 1) 
are remarkable as one considers the fact that the structure 
and the genesis of natural antibodies and MIPs are completely 
different. Antibodies are natural biomacromolecules of proteic 
nature produced by animals in response to an external immune 
stimulus [2]. Through a mechanism of clonal selection, not related 
to any conceivable imprinting mechanism, the cells of the immune 
system delegated to the production of antibodies are able to 
generate with high efficiency antibodies against virtually any 
foreign antigen, ranging from toxins and xenobiotic molecules to 
viruses and large bacteria. On the contrary, molecularly imprinted 
polymers are man-made artificial receptors obtained through 
a real imprinting mechanism during a polymerization process, 
where the presence of a template molecule inside the emerging 
cross-linked polymeric structure is able to induce the formation of 
stable binding sites with molecular recognition properties towards 
the same template or strictly related molecules.
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It is therefore not surprising that many investigators have 
thought of using polymers as artificial receptors in immunoassay-
like analytical applications. From the well-known seminal work 
of Mosbach and co-workers about a radiotracer assay for 
theophylline and diazepam based on very simple imprinted 
polymers [3], this idea has been subsequently reissued in a 
number of experimental works all based on the same principle: 
to replace natural antibodies with artificial receptors in so-called 
“molecularly imprinted sorbent assay”. This review wants to 
give a general overview of the most of the available literature, 
discussing which are the potential benefits and drawbacks of 
replacing natural antibodies with molecularly imprinted polymers.
2. What is immunoassay?
The immunoassay techniques have been introduced for the first 
time about fifty years ago simultaneously by Ekins for thyroid 
hormones [4] and Berson and Yalow for insulin analysis [5]. 
Both described competitive radioimmunoassays, and the main 
difference was that Berson and Yalow’s insulin assay used an 
antibody as the receptor whilst Ekins’ assay for thyroxin used 
the naturally occurring thyroxin binding globulin as the receptor. 
The development of immunoassay is perhaps one of the most 
important discovery in modern analytical biochemistry. It has 
made possible the easy quantification of substances hitherto 
either immeasurable or measurable using only lengthy and 
labour-intensive bioassays. Subsequently, it has pervaded 
most, if not, all branches of the biological sciences and has 
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in extremely complex samples, with minimum pre-treatment of 
the matrix.
According to Ekins [7], immunoassay techniques can be 
classified through three basic criteria:
(1) the presence/absence of a tracer molecule able to bind 
the analytical antibody (labelled / unlabelled assays). In the 
unlabelled format, the binding of the analyte to the analytical 
antibody is measured directly through the monitoring of physical 
of bulk effects due to the formation of the analyte-antibody 
complex. In the labelled format a tracer molecule similar 
to the analyte, able to generate a strong analytical signal is 
used to measure the extent of the analyte-antibody complex. 
Usually, tracers consist of molecules of analyte or an analogue 
marked with radionuclides (radioimmunoassay), enzymes 
become a vital tool in the clinical sciences. Nowadays, not only 
these techniques cover a pivotal function in clinical chemistry, 
but, under many formats, they play a growing role in different 
analytical fields of interests, involving analytes of environmental, 
food or forensic origin [6].
Immunoassay techniques are essentially based on the 
antibody-antigen reversible reaction and the subsequent 
quantitative measurement of the extant chemical species at 
the equilibrium. The specific interaction between antibodies 
and antigens provides the required analytical selectivity, while 
the high equilibrium constant provides high sensitivity for the 
assay. In consequence, the use of antibodies as highly selective 
analytical reagents in immunoassay is particularly appealing as it 
allows the direct quantitative analysis of sub-trace level analytes 
Natural antibodies Molecularly imprinted polymers
low-mass molecules (< 5000 Da) 
as immunogen / template
yes, but necessity of a covalent linker between the 
immunogenic carrier protein and the  low-mass 
antigen could affect the bindig selectivity of resulting 
antibodies 
yes, with exception for poorly functionalized or very 
low-mass molecules. Difficult for very polar templates
high-mass molecules (>5000 Da) 
as immunogen / template yes
yes, but with marked experimental difficulties for large 
proteins (difficult template release, poor selectivity) 
binding mechanism well known known, but some aspects under debate
binding affinity spectrum discrete and narrow for monoclonal antibodies, continuous and broad for polyclonal antibodies
discrete and narrow for covalent imprinting, 
continuous and broad for not-covalent imprinting
mean affinity constant frequently above 109 M-1 rarely exceeds 107 M-1 for bulk-imprinted polymers
binding site density low, mM  high, mmoles/g
binding kinetics fast association, slow dissociation slow association and dissociation
binding selectivity high, fine tuning for monoclonals feasible. Difficult to be obtained for classes of ligands 
high, fine tuning difficult when non-covalent approach 
is used
reproducibility limited from batch-to-batch very high
non-specific binding negligible depending from experimental conditions, rarely negligible
resistance to extreme 
experimental conditions 
(pH, cold, heat, sonication, 
organic solvents, denaturing 
agents)
no yes
resistance to biological agents no yes (can be autoclaved)
needs of a solid phase as support yes, this frequently involves the use of complex covalent coupling reactions no, the polymer itself can be the support
reuse very difficult yes
cost for single batch low for polyclonals, medium to high for monoclonals very low (except for expensive templates)
commercial availability high, frequently produced on demand limited
in-house feasibility no, a stabularium, trained people and a dedicated laboratory (monoclonals only) are necessary
yes, simple to make, with exceptions for advanced 
polymerization methods or mimic template 
approaches 
health risks not significative
sub-micrometric particles can be dangerous if 
inhaled. Some polymerization reagents (acrylamide, 
styrene, vinylpyridine) are toxic
literature very large very large and rapidly growing
state of the art mature in continuous evolution
Table 1.  A comparison between natural antibodies and molecularly imprinted polymers.
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present in the sample and it is bound to the analytical antibody. 
In this kind of assay the analytical antibody is usually immobilized 
on a solid surface and the competition is in solution between the 
analyte and a tracer. Alternatively (Figure 2), a fixed amount of 
analyte is immobilized onto a solid surface and it competes with 
the analyte in the sample for a fixed amount of labelled analytical 
antibody introduced in solution.
In the non-competitive format (Figure 3) an excess of 
analytical antibody is bound to the analyte, and the complex is 
then detected with a tracer able to bind the complex but not 
the free, non-bounded antibody in excess. This format is typical 
(enzyme immunoassay), fluorescent or luminescent molecules 
(fluorescence and luminescence immunoassay);
(2) the presence/absence of a competitive equilibrium 
between tracer and analyte for the binding site of the analytical 
antibody (competitive / non-competitive assays). In the 
competitive format (Figure 1) a variable amount of analyte 
compete with a fixed amount of tracer for a fixed and limited 
amount of antibodies, which is insufficient to bind all of the 
analyte and tracer molecules. The multiple equilibria due to the 
competition reaction results in a decrease of the analytical signal 
produced by the tracer when an increasing amount of analyte is 
Figure 1.  Schematic representation of a labelled, competitive, heterogeneous immunoassay with binding equilibria between a variable amount of 
analyte and a fixed amount of tracer for a fixed and limited amount of analytical antibody immobilized onto a solid surface.
Figure 2.  Schematic representation of a labelled, competitive, heterogeneous immunoassay with binding equilibria between a variable amount of 
analyte and a fixed amount of labelled analytical antibody for a fixed and limited amount of analyte immobilized onto a solid surface.
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assays can be explained by reasons of their poor sensitivity due 
to the usually low analytical signal generated by the ligand, while 
the absence of non-competitive assays may also be explained by 
the fact that, currently, it is quite difficult to obtain efficient MIPs 
with such characteristics, i.e., nanosized polymeric structures and 
molecular recognition properties focused on different epitopes 
present in the same target molecule. In consequence, it seems 
more appropriate to review the available literature in terms of 
the nature of the used tracer, and taking into the account that 
the overwhelming majority of the MIP-based immunoassays are 
labelled and competitive by default.   
3.1. Radiochemical tracers
Immunoassay based on radiochemical tracers 
(radioimmunoassay), typically 3H 14C or 125I-labeled molecules, 
has been a technique of enormous success, as the labelled 
ligand show the same binding behaviour of the target analyte, 
thus avoiding unwanted binding differences between tracer and 
analyte in the equilibrium reaction with the antibodies. In spite 
of the success of this technology, expensive costs to prepare 
labelled compounds not available in the market and growing 
concerns about the hazards of manipulate radiochemicals, 
united to legislative restrictions to detention, use and disposal 
of radionuclides caused the progressive decrease of popularity 
of this technique, and the concomitant raise of alternative, less 
troublesome, tracers.
The first molecularly imprinted sorbent assays reported 
in literature was a heterogeneous assay involving the use of 
of the so-called “sandwich assay”, where the analyte is large 
enough to have portions of the surface (epitopes) recognized 
by different, non cross-reacting, antibodies without any steric 
impediment. In this case, one of the antibodies (capture antibody) 
is bound in excess to a solid surface, then the analyte is absorbed 
by the capture antibody and the complex is quantified with the 
appropriately labelled second antibody. 
(3) the presence/absence of a separation step between the 
free and the antibody-bound tracer molecule (homogeneous / 
heterogeneous assays). In the homogenous assay the analyte 
bound to the analytical antibody does not need to be separated 
from the remaining free analyte as the analytical signal depends 
only by the presence of the immuno complex. On the contrary, 
in the heterogeneous assay the analyte bound to the analytical 
antibody must to be separated from the remaining free analyte 
before the development of the analytical signal.     
3. Molecularly imprinted sorbent assays
From the seminal work of Mosbach and co-workers [3], several 
papers concerning the design and the development of molecularly 
imprinted sorbent assays have been published. However, it is 
remarkable that of the eight possible formats resulting from the 
classification seen in the previous section, only assays based 
on labelled (except some fluorescence-based assays, that 
are unlabelled, see section 3.3), competitive, homogenous or 
heterogeneous formats have been reported. There may be many 
justifications to this fact, but mostly the absence of unlabelled 
Figure 3.  Schematic representation of a labelled, non-competitive, heterogeneous immunoassay (sandwich assay), where an excess of analytical 
antibody is bound to the analyte, and the complex is then detected with a tracer able to bind the complex but not the free, not-bounded 
antibody in excess.
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figure of merits resulted comparable with several corresponding 
commercially available immunoassays, demonstrating for the 
first time the feasibility of MIP-based immunoassays.
The feasibility of molecularly imprinted sorbent assays 
performed in organic solvents  has been further demonstrated in 
the years immediately prior to 2000 by the same research group, 
describing assays based on EDMA-co-MAA imprinted polymers 
for various target analytes: corticosteroids [8], morphine and 
[Leu5]encephalin [9], cyclosporine A [10] and atrazine [11]. When 
radiochemical tracers [3]. In this work molecularly imprinted 
ethylene dimethacrylate-co-methacrylic acid (EDMA-co-MAA) 
polymers for theophylline and diazepam were prepared by bulk 
polymerization and used to detect the corresponding analytes by 
competition with tritiated tracers. Even if selectivity in aqueous 
buffer and blood samples was not observed, the assays 
performed in organic extracts showed a good level of sensitivity 
(detection limits: 3.5 µM for theophylline, 0.2 µM for diazepam) 
and very good selectivity (Tables 2 and 3). It is remarkable that 
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CR50MIP: <1
CR50Ab: <1
ipoxanthine
CR50MIP: <1
CR50Ab: <1
1-methyluric acid
CR50MIP: <1
CR50Ab: <1
uric acid
CR50MIP: <1
CR50Ab: <1
Table 2.  Cross-reactivity of template analogs to the binding of [3H]-theophylline in toluene to a theophylline-imprinted MIP compared with correspondent 
commercial radioimmunoassay [3].
Table 3.  Cross-reactivity of template analogs to the binding of [3H]-diazepam in toluene to a diazepam-imprinted MIP compared with correspondent 
commercial radioimmunoassay [3].
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CR50MIP: 9
CR50Ab: 5
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CR50Ab: 1
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CR50MIP: 2
CR50Ab: <1
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1-100 µg/ml. Selectivity was good for ametryne and 
deethylatrazine, but not for propazine, which was recognized 
with a CR50 of 75%.   
In the same period, development of MIP-based assays 
working in aqueous buffers were described for yohimbine [13], 
(S)-propranolol [14,15] and 2,4-dichlorophenoxyacetic acid 
(2,4-D) [16]. When performed in phosphate buffer at pH 5, the 
assay for the α2-adrenoreceptor antagonist yohimbine showed 
a very good selectivity with respect to the very similar analog 
corinanthine, with IC50 of 1.8 µM (corinanthine IC50 = 340 µM) and 
an estimated limit of detection at level of 0.2 µM.
The assay for the β-blocker (S)-propranolol optimized in 
citrate buffer at pH 6 showed high template selectivity with 
respect to several structurally-related molecules ((S)-propranolol 
IC50 = 0.52 µM, (R)-propranolol IC50 = 3.0 µM, (R,S)-atenolol IC50 
= 76 µM, (R,S)-metoprolol IC50 = 170 µM, and (R,S)-timolol IC50 
= 770 µM) and a detection limit for the target analyte of 6 nM. 
When toluene was substituted to the aqueous buffer polymer 
in the assay, different selectivity profiles were obtained and the 
values for IC50 decreased of about one order of magnitude for all 
the ligands considered. The authors explained this fact as due to 
a different balance between hydrophobic and polar interactions 
in toluene and water, since polar interactions, such as hydrogen 
bonds, are strong in non-polar solvents and hydrophobic 
interactions are strong in water. The same effects were observed 
when the polymer formulation was modified by changing the 
cross-linker from ethylene dimethacrylate to trimethylolpropane 
trimethacrylate.
A EDMA-co-4VP (ethylene dimethacrylate-co-4-
vinylpyridine) polymer was used to develop an assay for the 
herbicide 2,4-dichlorophenoxyacetic acid. The effect of the 
buffer pH was studied in the range 3-9, finding a significant 
corticosterone and cortisol were used, the assays performed in 
tetrahydrofuran showed detection limits in the range 10-100 nM 
for both the analytes, while selectivity towards several related 
corticosteroids was very good, with cross-reactivity under 10% 
level and in accordance with selectivity measured for several 
commercial polyclonal antiserums.
Assays for morphine and [Leu5]encephalin were performed 
in mixed organic-aqueous medium, obtaining selectivity 
comparable with several commercially available monoclonal 
antibodies (Table 4). Interestingly, the assay for [Leu5]encephalin 
was developed by using the corresponding anilide as template 
mimic to enhance its solubility in the porogenic solvent during 
the polymerization process.
The assay for the immunosuppressant drug cyclosporine 
A was performed in diisopropyl ether after direct extraction of 
haemolysed blood samples. It showed good sensitivity at 100 
ng/ml level not only for the template, but also for several related 
and clinically relevant metabolites.
Atrazine was used to develop an assay working in toluene 
with a resulting limit of detection of about 0.1 µM. The authors 
evaluated the selectivity with a quite large library of potentially 
interfering substances, finding a negligible cross-reactivity for 
most of these, except for terbutylazine and desisopropylatrazine 
molecules very similar to the templating agent whose cross-
reactivity was found to be significant (CR50: 44% for terbutylazine 
and 53% for desisopropylatrazine). It is emphasized that also 
in this case the pattern of cross-reactivity is comparable to 
that reported in an aqueous environment in the case of mono- 
and polyclonal antibodies. A very similar assay for atrazine 
was independently developed by Moldoon and Stanker [12]. 
The assay, developed using 14C-atrazine as radiotracer, was 
optimized in acetonitrile, resulting with a dynamic range of 
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CR50(buffer): 100 
CR50(toluene): 100
codeine
CR50(buffer): 25 
CR50(toluene): 4.7 
normorphine
CR50(buffer): 9.9
CR50(toluene): 8.3 
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hydromorphone
CR50(buffer): 15 
CR50(toluene): 6.0
heroin
CR50(buffer): 8.3 
CR50(toluene): 2.3 
naloxone
CR50(buffer): 0.4 
CR50(toluene): <0.1
Table 4.  Effect of medium on the cross-reactivity of template analogs to the binding of [3H]-morphine to a morphine-imprinted polymer [9].
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assays based on radiochemical tracers is largely decreased after 
the year 2000. As for antibody-based  radioimmunoassay, the 
causes of this decline can be identified as unavailability in the 
market of isotopic-labelled tracers for many analytes of interests 
and to the legislative restrictions to detention, use and disposal 
of radionuclides. 
3.2. Enzymatic tracers
The use of enzyme-labelled antigens has been described as 
early as 1968 and it has become of the most popular labels for 
immunoassays, largely superseding radioimmunoassay [21,22]. 
Its popularity is mainly due to the absence of drawbacks typical 
of radiotracers, the commercial availability of many enzymes 
at low cost and high degree of purity and the easiness of 
conjugation with small- and large-mass antigens. Moreover, 
many enzyme labels, notably horseradish peroxidase and 
alkaline phosphatase, can be assayed using simple colorimetric/
fluorimetric reactions, thus not requiring more complex and 
expensive detection devices than an ordinary multichannel 
colorimetric/fluorimetric reader (microplate reader) [6].
The first enzyme-labelled molecularly imprinted sorbent 
assay reported in literature is a heterogeneous assay for the 
herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) [23]. The tracer 
was prepared by direct labelling of tobacco peroxidase with 
2,4-D, and the TRIM-co-4VP imprinted polymer was obtained 
by precipitation polymerization. When performed in phosphate 
buffer at pH 7, a preliminary assay performed with 3H-labeled 2,4-
D showed a very good selectivity with respect to some analogues 
of the template molecule (CR50: 25% for 4-chlorophenoxybutyric 
acid, 10% for 4-chlorophenoxyacetic acid and <0.1% for 
phenoxyethanol). Calibration curves obtained from sampling the 
unbound enzyme tracer after the end of the competition reaction 
resulted in a dynamic range of detection from 40 to 600 µg/ml 
in colorimetric detection mode (o-phenylenediamine/H2O2) and 
from 1 to 200 µg/ml in chemiluminiscence mode (luminol/H2O2).
In a following work, the same authors describing a microplate-
based assay based on the same 2,4-D-imprinted microbeads as 
described previously [24]. In this work, the microbeads were glued 
in microplate wells by using polyvinyl alcohol, and the amount of 
bound tracer was measured in chemiluminiscence mode (luminol/
H2O2) in a high-throughput imaging format with a CCD camera. 
The calibration curve resulted in a dynamic range from 0.01 to 
100 µg/ml. This assay was successfully applied to tap water 
spiked with the target analyte. In a further development, a flow-
injection competitive assay with chemiluminiscence detection 
analogous to the enzyme assays seen previously was developed 
using a 2,4-D-imprinted polymer grafted onto the inner surface of 
a glass capillary [25]. In this assay the 2,4-D-enzyme conjugate 
was fluxed together with the analyte through the capillary. After a 
washing step, the chemiluminescent substrate was injected and 
the bound fraction was quantified. The calibration curve resulted 
in a dynamic range from 0.5 ng/ml to 50 µg/ml in continuous mode 
and 5 to 100 pg/ml in stopped-flow mode. 
The development of imprinted microplates has been 
described by Piletsky and co-workers for an enzyme-labelled 
radiotracer rebinding in acidic conditions. When phosphate 
buffer pH 7 was used, a working range of 0.135-45 µM with a 
detection limit of about 0.1 µM was obtained. Selectivity was 
good with respect to several structurally-related herbicides 
(CR50: 24% for 4-chlorophenoxyacetic acid, 15% for 
2,4-dichlorophenylacetic acid, 10% for 4-chlorophenylacetic 
acid, 7% for 2,4-dichlorophenoxyacetic acid methylester, 2% for 
phenoxyacetic acid and <0.1% for phenoxyethanol). Interestingly, 
the long chain analog 2,4-dichlorophenoxybutyric acid was 
recognized at the same level of the template (CR50: 95%).
(S)-Propranolol was the target analyte considered for the 
development of a molecularly imprinted sorbent assay based on 
imprinted–magnetic iron oxide composite beads to separate the 
bound radiotracer from the unbound fraction [17]. Nanoparticles 
of magnetic iron oxide were incorporated using a suspension 
polymerisation methodology with a perfluorocarbon liquid as 
the dispersing phase for the preparation of imprinted TRIM-
co-MAA acrylic acid superparamagnetic microbeads. The 
assay optimized in citrate buffer at pH 6 showed high template 
selectivity with respect to some structurally-related molecules: 
(S)-propranolol (IC50=0.19 µM), (R)-propranolol (IC50=1.0 µM) and 
(R,S)-metoprolol (IC50 = 26.5 µM).
With the aim to facilitate the assay equilibration and the 
mass transfer process during the ligand rebinding process, 
competitive radiotracer assays have been developed for 
theophylline [18], 17α-estradiol [18] and 17β-estradiol [19] 
by using submicron-sized beads prepared by precipitation 
polymerization. The assays for theophylline and 17α-estradiol 
resulted highly selective for the template analytes when 
performed in acetonitrile. The assay for 17β-estradiol was not 
tested on real samples, but it was used to successfully screen 
for endocrine disrupting chemicals, showing high selectivity 
for the template molecule and a limited recognition for related 
17α-estradiol, estrone, and 17α-ethynylestradiol, with a cross-
selectivity of 14%, 5%, and 0.7%, respectively. 
Beside heterogeneous radiotracer-based assays, an 
example of homogenous assay format has been applied for (S)-
propranolol using the scintillation proximity approach [20]. In this 
approach a scintillation reporter monomer, 4-(hydroxymethyl)-
2,5-diphenyloxazole acrylate was covalently embedded in 
imprinted microspheres. When tritium-labelled analyte was 
rebounded to the beads, the β-emission from the radiotracer 
caused the reporter monomers near the binding site to fluoresce 
proportionally. If used in competitive format, the fluorescence 
signal decreases in effect of the presence of unlabelled analyte 
that competes with the radiotracer molecules for the occupation 
of the binding sites. The assay, performed in mixed acetonitrile-
citrate buffer solution, resulted selective for (S)-propranolol 
with respect to the (R)-enantiomer. It was optimized to detect 
(S)-propranolol in a working range of 1-1000 ng/ml, but no 
application on real samples was evaluated.
In conclusion of this section, it should be noted that, despite 
the undeniable advantage provided by the possibility of using 
tracers with molecular structure identical to the target analyte, 
the number of papers dealing with molecularly imprinted sorbent 
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are sensible to inactivation in organic solvents than radiochemical 
or fluorescent tracers. Enzymes are biomacromolecules 
characterized by slow diffusion in nanometre-sized pores 
typical of imprinted polymers, thus assay kinetics can be 
impractically slow. Last but not least, imprinted polymers have 
moderately hydrophobic surfaces, prone to irreversibly adsorb 
biomacromolecules like enzymes, in this manner increasing the 
analytical signal due to non-specific interactions.
3.3. Fluorescent tracers
Usually, in molecularly imprinted sorbent assays based on 
fluorescent tracers the target analyte is not fluorescent, and 
a fluorescent tracer can be used in a competitive approach 
(Table 5). This approach solves the difficulty of obtain proper 
analytical signals from poorly or completely non-fluorescent 
targets, and it is strongly competitive to the approach consisting 
in the cumbersome derivatisation of the target analyte with a 
fluorescent tag before of a non-competitive assay. Even though, 
the main limit of this approach frequently is the difficulty to obtain 
an imprinted polymer able to bind in the same manner both the 
target and the fluorescent tracer [33].
The first fluorescent molecularly imprinted sorbent assay 
was reported in literature by Piletsky and co-workers. It 
describes a competitive approach for triazine [34]. In this work 
the competing label was a fluorescent analog of the analyte, 
5-[(4,6-dichlorotriazin-2-yl)amino]fluorescein, and the analytical 
signal was given by the fluorescence of the free tracer at the 
equilibrium. The assay showed a dynamic range from 10 µM to 
100 mM, and resulted selective for triazine with respect to atrazine 
and simazine. The same tracer was used in a microplate-based 
assay [27]. In this approach, the bottom of the wells was grafted 
with a thin layer of imprinted poly-3-aminophenylboronic acid 
obtained by oxidation with ammonium persulphate. The assay 
performed in phosphate buffer at pH 6 resulted in a detection 
limit of 8 µM.
A fluorescent competitive assay is described by Piletsky 
and co-workers for the determination of chlorophenols in 
water [35]. The assay was based on the competition between 
pentachlorophenol-aminomethylcoumarin acetate as tracer and 
chlorophenols for the binding to a pentachlorophenol-imprinted 
TRIM-co-urocanic acid polymer. The competition reaction 
was performed on microfiltration plates in phosphate buffer at 
pH 7. The amount of unbound tracer was measured by HPLC 
analysis of the fluorescent product of the enzymatic reaction. 
The optimized conditions resulted in a dynamic range from 0.1 to 
25 µg/ml with a detection limit of 0.1 µg/ml). The assay was found 
to well recognize  chlorophenols other than pentachlorophenol 
(CR50: >95% 2,4,6-trichlorophenol, >95% 2,4-dichlorophenol, 
>95% 4-cyano-2,6-dibromophenol) but also several unrelated 
pesticides (CR50: 62% γ-hexachlorocyclohexane, 61% 
mecoprop, 58% diuron, 57% isoproturon, 56% chlorpyriphos, 
50% simazine, 45% glyphosate, 43% 2,4-dichlorophenoxyacetic 
acid, 37% hexachlorobenzene, 35% 2,4,6-trichlorobenzoic acid). 
The assay was applied to the analysis of pentachlorophenol in 
water and packaging materials.
assay for epinephrine [26,27]. In this approach, the bottom 
of the wells was grafted with a thin layer of imprinted poly-3-
aminophenylboronic acid obtained by oxidation with ammonium 
persulphate. Interestingly, the enzymatic tracer was obtained 
by the conjugation between horseradish peroxidase and 
norepinephrine, an analogue of the target analyte. The calibration 
curve performed on the optimized assay in phosphate buffer at pH 
6 resulted in a dynamic range from 1 to 100 µM when measured 
in colorimetric mode (ABTS/H2O2). The assay was found to 
be selective for epinephrine with respect to phenylephrine, 
(-)-isoproterenol, (+)-isoproterenol, norepinephrine and catechol. 
The same approach was used to prepare protein-imprinted 
microtitration plates with binding properties towards horseradish 
peroxidase, lactoperoxidase, microperoxidase and haemoglobin 
[28]. Rebinding studies and the determination of the affinity 
dissociation constant showed that the size and the charge of the 
template protein greatly affected the binding performances of 
the assay as negatively charged small proteins imprinted poly-
3-aminophenylboronic acid was better than positively charged 
large proteins. Competition studies performed in phosphate 
buffer at pH 7 on haemoglobin-imprinted microplates showed a 
certain degree of selectivity with respect to proteins like bovine 
serum albumin penicillin G acylase.
The use of 3-aminophenylboronic acid oxidation to prepare 
film of controlled thickness in the bottom of microplate wells has 
been reported by Wang and co-workers in an assay for estrone 
[29]. The use of an ionic liquid in the polymerization liquid mixture 
allowed a reduction of the cracking and shrinking of the imprinted 
films, facilitating the access of the horseradish peroxidase-
labelled conjugate to the binding sites. The calibration curve 
performed on the optimized assay in phosphate buffer at pH 
7 resulted in a detection limit of 8 ng/ml with a dynamic range 
from 5 ng/ml to 20 µg/ml when measured in colorimetric mode 
(TMB/H2O2). The assay was found to be moderately selective for 
estrone (CR50: 47% 17β-estradiol, 43% estriol, 30% progesterone 
and 40 diethylstilbestriol). The assay was applied to the analysis 
of estrone-spiked lake and river water at three concentration 
levels (100, 200, and 400 ng/ml) and validated by HPLC. The 
same authors have subsequently published some works about 
enzyme-tracer molecularly imprinted sorbent assays for the 
drugs ractopamine [30] and methimazole [31], and the pesticide 
trichlorfon [32]. The assay for ractopamin (IC50: 15.8 ng/ml, 
detection limit 10 ng/ml) was applied to fortified urine and pork 
samples with recoveries ranging from 77.7% to 108.9% (urine) 
and from 93.5% to 101.1% (pork). The assay for methimazole 
(IC50: 70 ng/ml, detection limit 1 ng/ml) was successfully applied 
to fortified urine samples with recoveries ranging from 90% to 
95%. The assay for trichlorfon (IC50: 6.8 µg/ml, detection limit
6.8 ng/ml) was successfully applied to fortified leek samples with 
recoveries ranging from 106% to 110.5%.
In conclusion of this section, the use of enzyme labels in 
molecularly imprinted sorbent assays is less problematic than 
the use of radiochemical tracers. However, some drawbacks are 
clearly present in enzymatic tracers. Imprinted polymers work 
well in organic or mixed aqueous/organic solutions but enzymes 
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same fluorescent tracer [39]. The detection limit was decreased 
to 0.197 µM with a dynamic range from 0.680 to 7.21 µM. 
Selectivity was observed for ampicillin, oxacillin, penicillin V, 
amoxicillin and nafcillin. The assay was successfully applied to 
spiked urine samples with excellent recoveries.
The use of imprinted core-shell microbeads prepared by 
controlled/living polymerization has been described by Lu and 
co-workers for a fluorescent competitive assay for the herbicide 
2,4-dichlorophenoxyacetic acid (2,4-D) [40]. By using as tracer 
the structurally related fluorophore 7-carboxymethoxy-4-
methylcoumarin, the authors obtained an assay in phosphate 
buffer at pH 7 with a dynamic range from 50 nM to 20 µM and 
a limit of detection of 10 nM. The use of surface-imprinted 
microbeads improved the assay performances with respect to 
bulk polymer but not the binding selectivity [36]. 
The same tracer has been used to develop an homogenous 
assay for 2,4-D based on the measurement of the decreasing 
of fluorescence polarization as a result of the binding events 
between the tracer, the analyte and imprinted nanospheres in 
phosphate buffer at pH 7 [41]. The limit of detection of the assay 
was 10 µM for 2,4-D, while selectivity was shown for the template 
molecule and the related herbicides 3,4-dichlorophenoxy acid 
and 2,4-dichlorophenoxybutyric acid.     
In conclusion of this section, as in the case for enzyme 
tracers, the use of fluorescent tracers in molecularly imprinted 
sorbent assays is much less problematic than the use of 
radiochemical tracers. Moreover, fluorimetric detection can be 
A fluorescent competitive assay for the herbicide 
2,4-dichlorophenoxyacetic acid in organic and aqueous solvents 
has been described by Haupt and co-workers [35,37]. In this 
approach the tracer is represented by 7-carboxymethoxy-4-
methylcoumarin, a molecule with limited similarity with the 
analyte. Notwithstanding the poor molecular recognition of the 
tracer by the imprinted polymer, in phosphate buffer at pH 7, 
the assay showed a dynamic range from 0.1 to 50 µM, with a 
detection limit of 0.1 µM and a good selectivity towards the 
target template with respect to related herbicides.
A non-related fluorescent tracers has been used by 
Moreno-Bondi and co-workers to develop fluorescent assays 
with shared selectivity towards penicillins [38]. The fluorescent 
tracers were synthesized conjugating the 6-aminopenicillanic 
acid structure typical of all the penicillins with pyrene or dansyl 
fluorescent tags. A library of six imprinted polymers prepared 
with penicillin G as template was screened for the efficient 
rebinding of penicillin G and fluorescent tracer. Pyrene-labelled 
penicillin G and the TRIM-co-MAA imprinted polymer provided 
the best assay for penicillin G in HEPES buffer at pH 7.5, with 
a dynamic range from 3 to 390 µM and a limit of detection of 
0.32 µM for penicillin G. Good recognition was seen for penicillin 
G-related antibiotics amoxicillin, ampicillin and penicillin V, but 
not for oxacillin, cloxacillin, dicloxacillin and nafcillin. Other 
antibiotics, such as chloramphenicol, tetracycline, or cephapirin 
were not recognized at all. An automated fluorescent assay for 
penicillins was subsequently developed by the authors using the 
Table 5.  Examples of fluorescent tracers used in molecularly imprinted sorbent assays for analytes reported in brakets.
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(triazines) [27,34]
aminomethylcoumarin-PCP
(pentachlorophenol) [35]
7-carboxymethoxy-4-methylcoumarin
(2,4-dichlorophenoxyacetic acid) [35-37,40,41]
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6-pyrenylamidopenicillanic acid
(penicillins) [38,39]
chloramphenicol-methyl red conjugate
(chloramphenicol) [42,43]
dansylchloramphenicol
(chloramphenicol) [44]
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chloramphenicol/thiamphenicol. The same assay was described 
by Suarez-Rodriguez [44], where the tracer was the fluorescent 
conjugate between chloramphenicol and dansylchloride. The 
assay, optimized for a packed photometric flow-cell, was found 
to be strongly dependent form of the concentration of the tracer 
in the mobile phase and the sample volume. The detection limit 
was 8 µg/ml and the working range was up to 100 µg /ml.     
The same approach was used by Piletsky and co-workers 
for the detection of several amino acids [45]. Rhodamine B 
was used as non-related fluorescent tracer in a competitive 
displacement assay on a L-phenylalaninamide-imprinted 
EDMA-co-MAA polymer packed in a HPLC column. Injections of 
template, D-phenylalaninamide, L-phenylalanine or L-tryptophan 
produced concentration dependent displacement of Rhodamine 
B from the polymer. 
5. Current limitations and perspectives
The feasibility of sorbent assays based on molecularly 
imprinted polymers as artificial substitutes of antibodies has 
been demonstrated by the experimental studies reported in 
the previous sections of this review. However, with respect to 
other research fields typical of molecular imprinting technology 
(solid phase extraction, sensoristics etc.), molecularly imprinted 
sorbent assays seem to find some difficulties to spread in the 
scientific community. Furthermore, unlike imprinted polymers 
for solid phase extraction applications, immunoassay kits 
based on this kind of materials are completely absent from the 
multimillionaire commercial immunoassay market.
To gain some insights about this difficulty, it is necessary to 
consider the “main competitor” of molecularly imprinted sorbent 
assay: the immunoassay. It is a quite old analytical technique, 
largely diffused in the scientific community, and its popularity is 
due to several strong points given below:
superior to colorimetric in terms of sensitivity of the assay and 
fluorescent tracers are more stable and solvent-compatible than 
enzymes. However , drawbacks may arise from the preparation 
of efficient fluorescent tracers as conjugates between fluorescent 
tags and analytes can be of difficult synthesis, products need 
to be isolated and purified, and the fluorescence properties 
(quantum yield, λmax of excitation/emission, etc.) of conjugates 
can be quite different from the same properties of the parent 
fluorophoric molecule. 
4. Molecularly imprinted displacement assays
In the so-called “displacement assay”, the antibody is covalently 
grafted onto a macroporous stationary phase packed in a capillary 
or in a chromatographic column. The binding sites of the antibody 
are saturated with a labelled antigen. Then, the analytical sample 
containing the unlabelled analyte is injected into the column, 
resulting in quantitative displacement of the bound tracer that is 
eluted and detected at the outlet of the column (Figure 4).
This assay has been applied using imprinted polymer 
instead of antibodies, using colorimetric or fluorimetric detection 
of the labelled antigens (Table 5). The first example is by  Karube 
and co-workers [42]. A chloramphenicol-methyl red conjugate 
was used as colorimetric tracer in a competitive displacement 
assay on chloramphenicol-imprinted EDMA-co-DEAEM (N,N-
diethylaminoethyl methacrylate) polymer packed in a HPLC 
column. Injections of chloramphenicol produced a concentration 
dependent displacement of the conjugate within a dynamic 
range from 5 to 1000 µg/ml with a detection limit of 5 µg/ml. The 
assay was successfully applied to serum samples spiked with 
10-20 µg/ml of chloramphenicol or its analogue thiamphenicol. 
In a further work [43], the authors used a monolithic imprinted 
polymer prepared in situ, slightly decreasing the detection 
limit to 3 µg/ml and increasing the selectivity for the couple 
Figure 4.  schematic representation of a displacement assay, where the antibody is immobilized onto a solid surface and its binding sites are saturated 
with a labelled antigen. The analytical sample containing the unlabelled analyte is added, resulting in a quantitative displacement of the 
bound tracer that is separated and quantified.
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(1) the most important drawback is related to the low 
sensitivity and specificity of the imprinted polymers if compared 
with immunoassay-grade antisera. Assay sensitivity can be 
related to the binding affinity of the analytical antibody used in 
the assay. Unfortunately, it seems that the present state–of-the-
art is not able to give us imprinted polymer characterized by 
very high binding affinity and enhanced selectivity. As recently 
observed [49], MIP/NIP pairs show a strong proportionality in 
the values for the binding affinities towards template molecules; 
thus, increasing the affinity of a MIP for a target molecule means 
to increase the affinity of the related NIP and, consequently, 
the probability that an interfering molecule could be bound by 
the MIP increase proportionally. At present, it is not clear if a 
recently proposed affinity technique which authors claim for able 
to isolate fractions of polymers with enhanced binding properties 
from pools of imprinted nanobeads will be useful to solve this 
problem [50,51]; 
(2) “Polyclonality” in MIPs, the presence of a continuous 
distribution of binding affinities ranging from very low to very 
high values, does not represent in itself a major issue, since 
polyclonal antisera with similar affinity spectra are always used 
in the development of immunoassays. The only necessary 
condition is obviously that the mean affinity value will be high. 
However, while in the case of polyclonal antisera selectivity 
remains the same for antibody fractions obtained by affinity 
chromatography and characterized by different mean affinity [52], 
in the case of the MIP it is not at all clear whether the selectivity 
may be influenced by the distribution of affinity, i.e., if classes 
of binding sites characterized by different mean affinity are also 
characterized by a different selectivity pattern. In this case, it is 
(1) high selectivity for target analyte also in very complex 
samples;
(2) no complex pre-treatment of the analytical samples 
required;
(3) high sensitivity (as a rule of thumb, in a competitive 
heterogeneous assay sensitivity a rough estimate of the possible 
detection limit is the inverse of the affinity constant);
(4) the methodological flexibility (competitive/non-
competitive, labelled/unlabelled, homogeneous/heterogeneous);
(5) the variability in the nature of possible tracers, going from 
the most common radiochemicals, enzymes or fluorophores to 
rare spin labels [46] or marker-filled liposomes [47];
(6) mono- and polyclonal antisera against virtually any 
possible target analyte are commercially available or, alternatively, 
they can be produced with limited efforts;
(7) antibodies can be chemically engineered, expressed 
as binding peptides in phage-display technology or otherwise 
modified to encounter the analytical necessities of modern 
immunoassay [2,48];
(8) immunoassay is cheap, the cost-per-sample 
(comprehensive of costs of instrumentation and personnel) is 
low.
(9) assays developed and optimized at research laboratory 
level can easily be converted in robust and stable commercial-
grade kits.   
Today, by comparing features and performances of imprinted 
polymer and antibody-based assays (see Table 6), it is easy to 
see that molecularly imprinted sorbent assay can cope with 
several of these features, but many others issues seem yet to 
be problematic:
Table 6.  Key features and performances of antibody- and MIP-based assays.
antibody-based MIP-based
low-mass analytes yes yes
high-mass analytes yes yes, but with marked experimental difficulties for large proteins
assay selectivity high, fine tuning feasible high, but fine tuning can be difficult
assay sensitivity very high (up to pg/ml) high (up to ng/ml)
non-specific tracer binding negligible depending from experimental conditions, rarely negligible
sample pretreatment very limited very limited
reproducibility high high
robustness moderate moderate
speed of execution fast fast
complexity of esecution moderate moderate
automatization yes possible
reusability no dubious
cost for single analysis low low
in-house feasibility yes yes 
commercial availability yes no
literature very large limited
state of the art mature in evolution
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mixture or introducing more flexible cross-linkers with the 
risk that polymer backbone flexibility will be achieved at the 
expense of molecular recognition properties [62]. At present, 
no definitive solution have been identified to cope with this 
issue, but the use of thermoresponsive co-monomers (typically 
N-isopropylacrylamide) seems to allow some flexibility in the 
imprinted binding sites without adversely affecting the molecular 
recognition [63,64].
6. Conclusions
In the last twenty years, molecularly imprinted sorbent assays 
developed slowly. Despite the feasibility of such assays has 
been shown for many formats, and as a proof-of-the-concept its 
efficacy has been demonstrated in many studies with respect to 
other fields of application typical of molecular imprinting, today 
molecularly imprinted sorbent assay is still at the developmental 
stage, and a certain number of relevant issues remain to be 
solved. However, it is reasonable that the constant advances 
in molecular imprinting technology in the coming years could 
help resolve these issues, enabling the development of more 
affordable and sophisticated assays and, in a more distant 
outlook, of commercial kits based on the molecularly imprinted 
sorbent assay technique.
therefore clear that any technique capable of isolating MIPs with 
controlled selectivity would be of big help to the development of 
highly selective molecularly imprinted sorbent assays; 
(3) high non-specific binding, polymer surface fouling by 
unwanted proteins and poor competition between enzyme-
labelled tracers and analytes can be related to the hydrophobicity 
of the MIP surface. In the past, many efforts have been made 
about “water-compatible” or “hydrophilic” MIPs [32,53-58], but 
it must be considered that the hydrophobic properties can play 
a decisive role in the interaction between the ligand and the 
binding site. Therefore, it seems still problematic to selectively 
suppress hydrophobic interactions outside the binding sites fully 
preserving those inside;    
(4) unlike binding sites of antibodies that are easily accessible 
and exhibit antigen-induced fit, in MIPs narrow porosity and 
rigidity of the polymer structure due to the high degree of 
crosslinking implies problems of steric hindrance at the entrance 
of the ligand in the binding site.  Consequently, binding kinetics 
can be very slow and unfavourable to the development of an 
assay, especially when analytes or tracers are represented by 
biomacromolecules. Surface grafting polymerization techniques 
could solve partially the issue of steric hindrance [59-61], while 
polymer rigidity can be reduced by decreasing the relative 
amount of cross-linker introduced in the pre-polymerization 
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